ArticleAsian Pacific journal of cancer prevention : APJCP2026
Dosimetric and Delivery Assessment of Stereotactic Body Radiotherapy Using Flattened and Unflattened Beams for the Single-Isocenter Treatment of Multiple Liver Targets.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStereotactic Body Radiotherapy (SBRT) is increasingly applied in the management of liver cancers. Flattening filter-free (FFF) beams, which offer higher dose rates, enable faster delivery and improved patient comfort. This retrospective study compares the dosimetric and delivery characteristics of SBRT using FFF and conventional flattened beams for the treatment of multiple liver targets.
methodsTwenty-six patients with 2-11 hepatic targets were treated using a single-isocenter volumetric modulated arc therapy (VMAT) technique. Treatment plans were created for 6X, 6FFF, and 10FFF photon beams, with prescription doses ranging from 27.5 Gy to 50 Gy in 5 fractions. Plan evaluation metrics included Planning Target Volume (PTV) coverage (V95%, V98%, V100%), mean liver dose (MLD), normal liver volume receiving <15 Gy, and maximum doses to Organs at Risk (OARs). Delivery parameters were assessed by gamma passing rate, monitor units (MU), and beam-on time (BOT). Repeated-measures ANOVA, with post-hoc least significant difference (LSD) testing, was used for statistical analysis.
resultsComparable Planning Target Volume (PTV) coverage was achieved with all beam modalities. No statistically significant differences were noted in mean liver dose (MLD), normal liver volume receiving <15 Gy, or other Organ at Risk (OAR) doses, except for lower spinal cord doses with FFF beams (p = 0.003). The 2%/2 mm gamma passing rate for 6FFF was 1% lower than for 6X and 10FFF. Monitor unit (MU) values were higher for 6FFF (4.3%) and 10FFF (1.5%) compared with 6X (p = 0.01). Beam-on time (BOT) was significantly shorter with 6FFF (3.8 ± 0.28 min) and 10FFF (3.8 ± 0.30 min) relative to 6X (5.1 ± 0.22 min) (p = 0.001).
conclusionFlattening filter-free (FFF) beams reduce beam-on time (BOT), providing an advantage for breath-hold techniques. However, despite the higher dose rate of 10FFF, no additional reduction in overall treatment time was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.